Related Experiment Videos
Subconjunctival corticosteroid therapy complicated by hyperinfective strongyloidiasis
American Journal of Ophthalmology
|June 1, 1980
Summary
Subconjunctival corticosteroids can trigger hyperinvasive strongyloidiasis in asymptomatic carriers. This case highlights the risk of disseminated Strongyloides infection following corticosteroid therapy.
Area of Science:
- Ophthalmology
- Infectious Diseases
- Gastroenterology
Background:
- Corticosteroids are commonly used in ophthalmology for treating inflammatory conditions.
- Strongyloides stercoralis is an intestinal nematode that can cause chronic asymptomatic infections.
Observation:
- A patient receiving subconjunctival dexamethasone for a corneal ulcer developed severe gastrointestinal strongyloidiasis.
- The patient presented with peptic ulcer hemorrhage, gastric outlet obstruction, and disseminated infection.
- Complications included meningitis and Serratia marcescens bacteremia.
Findings:
- Subconjunctival corticosteroid administration led to systemic immunosuppression.
- This immunosuppression transformed an asymptomatic Strongyloides infection into hyperinvasive strongyloidiasis.
- The patient's eosinophil count was noted prior to therapy.
Implications:
- Physicians should consider screening for Strongyloides in patients with risk factors before initiating corticosteroid therapy.
- This case underscores the potential systemic effects of localized corticosteroid injections.
- Early recognition and treatment of disseminated strongyloidiasis are crucial for patient survival.